Biopharmaceutical Market - Forecast(2021 - 2026)

Report Code: HCR 0054 Report Format: PDF + Excel (Delivery in 48 Hrs)

Biopharmaceutical market Overview

The Biopharmaceutical Market size is $239.8 Billion in 2019, growing at a CAGR of 13.28% during the forecast period 2020-2025. The rapid pace of scientific advancements enables greater insight into diseases at the molecular level. As a result, Biopharmaceutical companies execute basic research in collaboration with researchers to seek powerful tools and molecular medicines to better understand human diseases. While basic science offers a foundation of drug developments, the biopharmaceutical industry is thus, largely driven by an increasing number of chronic diseases, a growing geriatric population and rising awareness towards targeted therapy. Furthermore, to effectively address untreatable diseases, the demand for biopharmaceutical medicines across the world accelerates Biopharmaceuticals in the global market.

Report Coverage

The report: “Biopharmaceutical Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Biopharmaceutical Market.
By Product Type: Cell and Gene Therapies, Hormones, Vaccines, Enzymes, Blood Components, Cell and Gene Therapies, Monoclonal Antibodies, Growth Factors, Gene Therapies, Thrombolytics and Anticoagulants, Recombinant Protein and others.
By Therapeutic Application: Oncology, Inflammatory Diseases, Cardiology, Neurology, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders and Others.
By End-Use Industry: Health and Care, Biopharma Companies, Diagnostic Labs, Clinical Research Institute and CROs
By Geography: North America, Europe, Asia-Pacific and Rest of the World.

Key Takeaways

  • North America is anticipated to dominate the global biopharmaceutical market in the forecast period 2020-2025 attributed to address human health challenges and simultaneously, translate scientific breakthroughs into effectual treatment, and deliver authentic healthcare innovation worldwide.
  • Biopharmaceutical innovation contributes to the premature death averages and decrease of mortality rate, along with designing new biodrug for the emergence of distinct types of diseases, mutation of viruses and microbes. The rise in strategic collaboration among the Research developments and Biopharmaceuticals companies is accelerating the respective market.
  • Detailed analysis of the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Biopharmaceutical market report.

Biopharmaceutical Market Segment Analysis - By Product Type

Based on Product Type, the biopharmaceutical market is segmented into Cell and Gene Therapies, Hormones, Vaccines, Enzymes, Blood Components, Cell and Gene Therapies, Monoclonal Antibodies, Growth Factors, Gene Therapies, Thrombolytics and Anticoagulants, Recombinant Protein, and others. Monoclonal antibodies hold the largest Biopharmaceutical market share, owing to exponential research and applications in the oncology department. Depending on the global biopharmaceuticals market, a monoclonal antibody segment is a powerful tool of biochemistry, molecular biology, and medicine. Also termed as ‘MAbs’, the key advantages are diagnosis and treatment of ‘cancer’, ‘myocardial infractions’, developing a therapy for ‘neoplastic and hematopoietic disease’ and many more remedial treatments in a quicker and less expensive way, abetting towards the growth of the market. Recombinant Hormone Therapy is set to be the fastest growing with a CAGR of 15.5% during the forecast period 2020-2025. This is owing to treat major diseases like congestive heart failure, diabetes, multiple sclerosis and many severe illnesses. 

Biopharmaceutical Market Segment Analysis - By End-Use Industry 

Based on End-Use Industry segment, the biopharmaceutical market is segmented into Health and Care, Biopharma Companies, Diagnostic Labs, Clinical Research Institute and CROs. Biopharma Companies holds the major share in the biopharmaceutical market owing to considerable augmentation of developing potential new medicines. As previously mentioned, Biopharma Companies role in drug innovation is increasing owing to recent advancement across molecular medicine that has led the biopharma companies to personalize medicine. Personalized medicines can potentially serve respective patients faster diagnoses, lesser side effects and desired outcomes. Clinical Research Institute is set to be the fastest growing CAGR during the forecast period 2020-2025, owing to ensure the safety and efficacious personalized treatment that are practiced alongside modified clinical trial protocols.

Biopharmaceutical Market Segment Analysis -Geography

Based on Geography, biopharmaceutical market is segmented into North America, Europe, Asia-Pacific and Rest of the World. The North America region dominated the Biopharmaceutical market in 2019 with a share of 38.91%.  This is owing to the colossal challenges to deliver authentic healthcare innovation worldwide, and to promote newly-developed biodrugs to address human health challenges. Asia Pacific is set to be the fastest growing CAGR during the forecast period 2020-2025 owing to promising investment by the government and varied unmet industry opportunities. 

Biopharmaceutical Market Drivers

Rising Trend to develop Efficiency and Productivity

Over the years, there have been constant innovations of new technologies in the field of biopharmaceutics. The global Biopharmaceutical Market is primarily driven by the strategic investment in biodrugs research and development along with the marketing of innovative healthcare solutions, like new medicines. Moreover, Suppliers require to gear their advanced clinical technologies toward developing ‘biologics’ better, faster and cheaper. To plan for the future is the utmost necessity that specifies future-proofed medicines, denoting longevity and welfare to the population, which again contributes to the growth of the Biopharmaceutical Market.

Bringing More Products and Players

There is a rapid advancement for bringing diversified new bioprocessing facilities and players by Biosimilars and thus, drives the growth of the Biopharmaceutical Market. As discussed earlier, the need to develop cost-effective manufacturing is imperative, for offering considerable health care price framework to the patients. Thus, developing ‘biobetter’, ‘biosimilar’ and ‘biogenerics’ products is signified as benevolent measures across developing countries to manage overwhelming health issues.

Biopharmaceutical Market Challenges

Major Pharmaceutical Protocols Concerns

The key restrictive factors for market growth are stringent pharmaceutical protocols faced by the health professionals, biopharmaceutical companies and stakeholders. There are a lot of struggles and challenges associated with the innovation with the new drugs, and also, during the promotion of such novel products. As every new drug goes through several procedures before the launch and marketing, and among these stages, there are animals and clinical studies to report. Lack of laboratory animal supplies is one of the challenges, for scientific tests owing to regulatory concern by the animal rights authority.

Biopharmaceutical Market Industry Outlook

Product Launches, Merger & Acquisition, joint ventures and R&D activities are key strategies adopted by the players in the Biopharmaceutical Market. Biopharmaceutical Market top 10 companies include Roche Holding AG, Abbott Laboratories, Bristol-Myers Squibb, Novartis International AG, Genentech Inc., Merck Serono, Amgen, BioMarin Pharmaceutical Inc., Invion Limited and Élan Corporation.

Acquisitions/Product Launches:

  • In November 2019, Novartis acquired The Medicines Company, the US-based biopharmaceutical company for USD 9.7 Bn to deliver breakthrough cardiovascular treatments by ‘Inclisiran’, a potentially transformational investigational cholesterol-lowering therapy.
For more Lifesciences and Healthcare related reports, please click here
1. Biopharmaceutical Market Overview
    1.1 Definitions and Scope
2. Biopharmaceutical Market Executive Summary
    2.1 Marketrevenue, Market Size and Key Trends 
    2.2 Key trends by Product Type
    2.3 Key trends by Therapeutic Application
    2.4 Key trends by End Use
    2.5 Key trends by Geography
3. Biopharmaceutical Market Landscape
    3.1 MarketShare Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Biopharmaceutical Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Biopharmaceutical Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Biopharmaceutical Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Biopharmaceutical Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Biopharmaceutical Market – By Product Type (Market Size - $Million/$Billion)
    8.1 Cell and Gene Therapies
    8.2 Monoclonal Antibodies
    8.3 Hormones
    8.4 Vaccines 
    8.5 Enzymes
    8.6 Blood Components
    8.7 Cell and Gene Therapies 
    8.8 Growth Factors
    8.9 Gene Therapies
    8.10 Thrombolytics and Anticoagulants
    8.11 Recombinant Protein
    8.12 Others 
9. Biopharmaceutical Market– By Therapeutic Application (Market Size - $Million/$Billion)
    9.1 Oncology
    9.2 Inflammatory Diseases
    9.3 Cardiology 
    9.4 Neurology 
    9.5 Autoimmune Disorders
    9.6 Metabolic Disorders
    9.7 Hormonal Disorders
    9.8 Others
10. Biopharmaceutical Market– By End Use (Market Size - $Million/$Billion)
    10.1 Health and Care
    10.2 Biopharmaceutical Companies
    10.3 Diagnostic Labs
    10.4 Clinical Research Institute 
    10.5 CROs
11. Biopharmaceutical Market- By Geography (Market Size - $Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 France
        11.2.6 Netherlands 
        11.2.7 Spain
        11.2.8 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Biopharmaceutical Market Entropy
13. Biopharmaceutical Market - Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. Biopharmaceutical Market- Key Company List by Country Premium Premium
15. Biopharmaceutical Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 Company 1
    15.3 Company 2
    15.4 Company 3
    15.5 Company 4
    15.6 Company 5
    15.7 Company 6
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables:

Table 1: Biopharmaceutical Market Overview 2021-2026
Table 2: Biopharmaceutical Market Leader Analysis 2018-2019 (US$)
Table 3: Biopharmaceutical Market Product Analysis 2018-2019 (US$)
Table 4: Biopharmaceutical Market End User Analysis 2018-2019 (US$)
Table 5: Biopharmaceutical Market Patent Analysis 2013-2018* (US$)
Table 6: Biopharmaceutical Market Financial Analysis 2018-2019 (US$)
Table 7: Biopharmaceutical Market Driver Analysis 2018-2019 (US$)
Table 8: Biopharmaceutical Market Challenges Analysis 2018-2019 (US$)
Table 9: Biopharmaceutical Market Constraint Analysis 2018-2019 (US$)
Table 10: Biopharmaceutical Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Biopharmaceutical Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Biopharmaceutical Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Biopharmaceutical Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Biopharmaceutical Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Biopharmaceutical Market Value Chain Analysis 2018-2019 (US$)
Table 16: Biopharmaceutical Market Pricing Analysis 2021-2026 (US$)
Table 17: Biopharmaceutical Market Opportunities Analysis 2021-2026 (US$)
Table 18: Biopharmaceutical Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Biopharmaceutical Market Supplier Analysis 2018-2019 (US$)
Table 20: Biopharmaceutical Market Distributor Analysis 2018-2019 (US$)
Table 21: Biopharmaceutical Market Trend Analysis 2018-2019 (US$)
Table 22: Biopharmaceutical Market Size 2018 (US$)
Table 23: Biopharmaceutical Market Forecast Analysis 2021-2026 (US$)
Table 24: Biopharmaceutical Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 26: Biopharmaceutical Market By Source, Revenue & Volume, By Unicellular System, 2021-2026 ($)
Table 27: Biopharmaceutical Market By Source, Revenue & Volume, By Bacteria, 2021-2026 ($)
Table 28: Biopharmaceutical Market By Source, Revenue & Volume, By Yeast, 2021-2026 ($)
Table 29: Biopharmaceutical Market By Source, Revenue & Volume, By Insect, 2021-2026 ($)
Table 30: Biopharmaceutical Market By Source, Revenue & Volume, By Multicellular System, 2021-2026 ($)
Table 31: Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 32: Biopharmaceutical Market By Product, Revenue & Volume, By Vaccines, 2021-2026 ($)
Table 33: Biopharmaceutical Market By Product, Revenue & Volume, By Hormones, 2021-2026 ($)
Table 34: Biopharmaceutical Market By Product, Revenue & Volume, By Enzymes, 2021-2026 ($)
Table 35: Biopharmaceutical Market By Product, Revenue & Volume, By Blood, 2021-2026 ($)
Table 36: Biopharmaceutical Market By Product, Revenue & Volume, By Blood Components, 2021-2026 ($)
Table 37: Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 38: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Single-Use System, 2021-2026 ($)
Table 39: Biopharmaceutical Market By Manufacturing Process, Revenue & Volume, By Multi- Use System, 2021-2026 ($)
Table 40: Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 41: Biopharmaceutical Market By Application, Revenue & Volume, By Rheumatology, 2021-2026 ($)
Table 42: Biopharmaceutical Market By Application, Revenue & Volume, By Oncology, 2021-2026 ($)
Table 43: Biopharmaceutical Market By Application, Revenue & Volume, By Cardiology, 2021-2026 ($)
Table 44: Biopharmaceutical Market By Application, Revenue & Volume, By Dermatology, 2021-2026 ($)
Table 45: Biopharmaceutical Market By Application, Revenue & Volume, By Gastroenterology, 2021-2026 ($)
Table 46: Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 47: Biopharmaceutical Market By End Use, Revenue & Volume, By Biopharmaceutical Companies, 2021-2026 ($)
Table 48: Biopharmaceutical Market By End Use, Revenue & Volume, By Hospitals, 2021-2026 ($)
Table 49: Biopharmaceutical Market By End Use, Revenue & Volume, By Research Institutes, 2021-2026 ($)
Table 50: Biopharmaceutical Market By End Use, Revenue & Volume, By CROs, 2021-2026 ($)
Table 51: Biopharmaceutical Market By End Use, Revenue & Volume, By Diagnostic Labs, 2021-2026 ($)
Table 52: North America Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 53: North America Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 54: North America Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 55: North America Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 56: North America Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 57: South america Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 58: South america Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 59: South america Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 60: South america Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 61: South america Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 62: Europe Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 63: Europe Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 64: Europe Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 65: Europe Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 66: Europe Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 67: APAC Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 68: APAC Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 69: APAC Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 70: APAC Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 71: APAC Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 72: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 73: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 74: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 75: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 76: Middle East & Africa Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 77: Russia Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 78: Russia Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 79: Russia Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 80: Russia Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 81: Russia Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 82: Israel Biopharmaceutical Market, Revenue & Volume, By Source, 2021-2026 ($)
Table 83: Israel Biopharmaceutical Market, Revenue & Volume, By Product, 2021-2026 ($)
Table 84: Israel Biopharmaceutical Market, Revenue & Volume, By Manufacturing Process, 2021-2026 ($)
Table 85: Israel Biopharmaceutical Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 86: Israel Biopharmaceutical Market, Revenue & Volume, By End Use, 2021-2026 ($)
Table 87: Top Companies 2018 (US$)Biopharmaceutical Market, Revenue & Volume
Table 88: Product Launch 2018-2019Biopharmaceutical Market, Revenue & Volume
Table 89: Mergers & Acquistions 2018-2019Biopharmaceutical Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Biopharmaceutical Market 2021-2026
Figure 2: Market Share Analysis for Biopharmaceutical Market 2018 (US$)
Figure 3: Product Comparison in Biopharmaceutical Market 2018-2019 (US$)
Figure 4: End User Profile for Biopharmaceutical Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Biopharmaceutical Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Biopharmaceutical Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Biopharmaceutical Market 2018-2019
Figure 8: Ecosystem Analysis in Biopharmaceutical Market 2018
Figure 9: Average Selling Price in Biopharmaceutical Market 2021-2026
Figure 10: Top Opportunites in Biopharmaceutical Market 2018-2019
Figure 11: Market Life Cycle Analysis in Biopharmaceutical Market
Figure 12: GlobalBy SourceBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy ProductBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 14: GlobalBy Manufacturing ProcessBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 15: GlobalBy ApplicationBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 16: GlobalBy End UseBiopharmaceutical Market Revenue, 2021-2026 ($)
Figure 17: Global Biopharmaceutical Market - By Geography
Figure 18: Global Biopharmaceutical Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 19: Global Biopharmaceutical Market CAGR, By Geography, 2021-2026 (%)
Figure 20: North America Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 21: US Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 34: Brazil Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 63: U.K Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 96: China Biopharmaceutical Market Value & Volume, 2021-2026
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($)Biopharmaceutical Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Biopharmaceutical Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 125: Russia Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Biopharmaceutical Market Value & Volume, 2021-2026 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%)Biopharmaceutical Market
Figure 134: Developments, 2018-2019*Biopharmaceutical Market
Figure 135: Company 1 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 8 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Biopharmaceutical Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Biopharmaceutical Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Biopharmaceutical Market Net Sales Share, By Geography, 2018 (%)